Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Liver X receptor α mediates hepatic triglyceride accumulation through upregulation of G0/G1 Switch Gene 2 expression
Bradlee L. Heckmann, … , Rudolf Zechner, Jun Liu
Bradlee L. Heckmann, … , Rudolf Zechner, Jun Liu
Published February 23, 2017
Citation Information: JCI Insight. 2017;2(4):e88735. https://doi.org/10.1172/jci.insight.88735.
View: Text | PDF
Research Article Hepatology Metabolism

Liver X receptor α mediates hepatic triglyceride accumulation through upregulation of G0/G1 Switch Gene 2 expression

  • Text
  • PDF
Abstract

Liver X receptors (LXRs) are transcription factors essential for cholesterol homeostasis and lipogenesis. LXRα has been implicated in regulating hepatic triglyceride (TG) accumulation upon both influx of adipose-derived fatty acids (FAs) during fasting and stimulation of de novo FA synthesis by chemical agonism of LXR. However, whether or not a convergent mechanism is employed to drive deposition of FAs from these 2 different sources in TGs is undetermined. Here, we report that the G0/G1 Switch Gene 2 (G0S2), a selective inhibitor of intracellular TG hydrolysis/lipolysis, is a direct target gene of LXRα. Transcriptional activation is conferred by LXRα binding to a direct repeat 4 (DR4) motif in the G0S2 promoter. While LXRα–/– mice exhibited decreased hepatic G0S2 expression, adenoviral expression of G0S2 was sufficient to restore fasting-induced TG storage and glycogen depletion in the liver of these mice. In response to LXR agonist T0901317, G0S2 ablation prevented hepatic steatosis and hypertriglyceridemia without affecting the beneficial effects on HDL. Thus, the LXRα-G0S2 axis plays a distinct role in regulating hepatic TG during both fasting and pharmacological activation of LXR.

Authors

Bradlee L. Heckmann, Xiaodong Zhang, Alicia M. Saarinen, Gabriele Schoiswohl, Erin E. Kershaw, Rudolf Zechner, Jun Liu

×

Figure 2

LXRα and RXRα are required for hepatic G0S2 expression in response to fasting and acute stimulation of adipose lipolysis.

Options: View larger image (or click on image) Download as PowerPoint
LXRα and RXRα are required for hepatic G0S2 expression in response to fa...
For panels A and B, 12-week-old female WT and LXRα KO mice were fasted for 16 hours. (A) qPCR analysis of G0S2, ATGL, LXRα, and LXRα target genes in liver. (B) Immunoblot analysis of G0S2 and ATGL expression in liver from 16-hour fasted WT and LXRα KO mice. For panels C and D, 14-week-old female WT and LXRα KO mice were injected with 0.1 mg/kg CL316243 for 1 hour. (C) qPCR analysis of hepatic G0S2, ATGL, LXRα, and LXRα target genes in response to CL injection. (D) Immunoblot analysis of G0S2 and ATGL expression in liver following acute CL injection in WT and LXRα KO mice. For panels E and F, 14-week-old female WT mice were injected with vehicle or HX531 and then fasted for 16 hours. (E) qPCR analysis of hepatic G0S2 and ATGL expression. (F) Immunoblot analysis of G0S2 and ATGL expression in fasted liver. For panels G and H, 15-week-old female WT mice were injected with CL316243 as described above in the presence or absence of HX531. (G) qPCR analysis of G0S2 and ATGL from liver. (H) Immunoblot analysis for hepatic G0S2 and ATGL in CL/HX531 mice. Box-and-whisker plots depict median (line within box), 25th percentile and 75th percentile (bottom and top borders), and range of minimum to maximum values (whiskers; n = 7 [A and C], n = 5 [E and G] for qPCR performed in triplicate; *P < 0.05, **P < 0.01, ***P < 0.001, Student’s t test).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts